<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02740244</url>
  </required_header>
  <id_info>
    <org_study_id>1018 rTMS DEP BIP</org_study_id>
    <nct_id>NCT02740244</nct_id>
  </id_info>
  <brief_title>Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression</brief_title>
  <acronym>iTBS-BIP</acronym>
  <official_title>Effects of Intermittent Theta Burst Stimulation Applied Over the Left Dorsolateral Prefrontal Cortex in Patients With Treatment-resistant Bipolar Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to evaluate the evaluate the clinical interest and the safety of repetitive
      transcranial magnetic stimulation (rTMS) delivered as intermittent Theta burst
      stimulation(iTBS) on severity of depression in patients with treatment-resistant bipolar
      disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: A double-blind randomized sham-controlled pilot study will be conducted in 40
      patients with bipolar treatment-resistant depression receiving either active (n=20) or sham
      (n=20) iTBS over the left dorsolateral prefrontal cortex.

      Depression severity will be assessed by an investigator blinded to iTBS condition before and
      after 10 to 30 iTBS sessions depending on remission onset. Remission will be defined as Beck
      Depression Inventory, BDI score&lt;10.

      Objective/Hypothesis: The investigators hypothesized the superiority of active iTBS over sham
      ITBS
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    difficulties of recruitment
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>2 time point measure, before and after the end of stimulation sessions (changes from baseline BDI scores at 6 weeks)</time_frame>
    <description>Self-reported clinical scale with 13 items</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Bipolar Depression</condition>
  <arm_group>
    <arm_group_label>active iTBS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive 10 to 30 sessions of active intermittent theta burst stimulation (iTBS) consisting in delivering 2 s train of bursts containing three pulses at 50 Hz repeated each 200 ms every 10 s (iTBS). Each iTBS session contained 990 pulses and lasted 6 min. Stimulation intensity will be set at 80% of the patient's resting motor threshold. iTBS will be applied twice per day, with at least three hours between each session. Ten to 30 sessions will be delivered until patient achieved remission (i.e., 13-item Beck Depression Inventory (BDI13) score &lt; 10). iTBS will be applied over the left dorsolateral prefrontal cortex (DLPFC) according to the individual's 3D-T1 MRI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham iTBS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The same protocol (location, intensity, parameters of stimulation) will be applied using a commercial sham coil.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active iTBS</intervention_name>
    <description>Transcranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a figure-eight coil (MCF-B65)</description>
    <arm_group_label>active iTBS</arm_group_label>
    <other_name>intermittent Theta Burst stimulation; rTMS stimulator, rTMS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham iTBS</intervention_name>
    <description>Transcranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a sham figure-eight coil (MCF-P-B65)</description>
    <arm_group_label>sham iTBS</arm_group_label>
    <other_name>sham intermittent Theta Burst stimulation; sham rTMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders,
             DSM-IV criteria

          -  Montgomery and Asberg depression scale &gt; 20

        Exclusion Criteria:

          -  other psychiatric features, rapid cycles

          -  Benzodiazepines intake

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Szekely, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

